News Release

CBIO submits Form 8-K regarding its Nasdaq listing status

Please be advised that Catalyst Biosciences, Inc. (CBIO), one of our affiliates, filed 8-K to SEC today regarding its listing status at Nasdaq.

For more details, please refer to the link below.

This document is created purely for the purpose of publicly announcing CBIO’s official filing with SEC and NOT for the purpose of soliciting investment either in Japan or overseas.